This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://localhost/temp/predkladatel/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/resource/domain/vavai/subjekt/
n13http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n15http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F12%3A33140631%21RIV13-MSM-15110___/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F12%3A33140631%21RIV13-MSM-15110___
rdf:type
skos:Concept n13:Vysledek
dcterms:description
In the past decade, it has been realized that rather than a single entity, breast cancer represents a spectrum of neoplastic disorders affecting the same organ (1-4). The expression of human epidermal growth factor receptor-2 (HER-2) is characteristic of subtype(s) of breast cancer with an unfavorable prognosis. In the past decade, it has been realized that rather than a single entity, breast cancer represents a spectrum of neoplastic disorders affecting the same organ (1-4). The expression of human epidermal growth factor receptor-2 (HER-2) is characteristic of subtype(s) of breast cancer with an unfavorable prognosis.
dcterms:title
Targeted therapy for HER-2: personalized medicine for her, too Targeted therapy for HER-2: personalized medicine for her, too
skos:prefLabel
Targeted therapy for HER-2: personalized medicine for her, too Targeted therapy for HER-2: personalized medicine for her, too
skos:notation
RIV/61989592:15110/12:33140631!RIV13-MSM-15110___
n13:predkladatel
n14:orjk%3A15110
n3:aktivita
n8:I
n3:aktivity
I
n3:cisloPeriodika
1
n3:dodaniDat
n12:2013
n3:domaciTvurceVysledku
n4:5290791
n3:druhVysledku
n19:J
n3:duvernostUdaju
n11:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
173266
n3:idVysledku
RIV/61989592:15110/12:33140631
n3:jazykVysledku
n17:eng
n3:klicovaSlova
lapatinib; docetaxel; capecitabine; plus; antibody; efficacy; expression; trastuzumab; adjuvant chemotherapy; metastatic breast-cancer
n3:klicoveSlovo
n6:lapatinib n6:antibody n6:efficacy n6:metastatic%20breast-cancer n6:docetaxel n6:adjuvant%20chemotherapy n6:plus n6:capecitabine n6:expression n6:trastuzumab
n3:kodStatuVydavatele
DE - Spolková republika Německo
n3:kontrolniKodProRIV
[DA5452AF5FC4]
n3:nazevZdroje
Clinical Chemistry and Laboratory Medicine
n3:obor
n18:FD
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n12:2012
n3:svazekPeriodika
50
n3:tvurceVysledku
Melichar, Bohuslav Plebani, Mario
s:issn
1434-6621
s:numberOfPages
4
n15:doi
10.1515/CCLM.2011.724
n7:organizacniJednotka
15110